chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: developed facial numbness within minutes of getting the second shot.; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date in Jan2021 as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2, lot number unknown, via an unspecified route of administration on an unspecified date, as single dose for COVID-19 immunization. The patient was perplexed as to why the patient information on the COVID-19 vaccine stated that adverse neurological effects cannot definitively be associated with the vaccine. The patient developed facial numbness within minutes of getting the second shot and she still had it 7 months out. The outcome of the event was not recovered.  The lot number for BNT162B2, was not provided and will be requested during follow up.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia
Clinical narrative: developed facial numbness within minutes of getting the second shot.; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date in Jan2021 as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2, lot number unknown, via an unspecified route of administration on an unspecified date, as single dose for COVID-19 immunization. The patient was perplexed as to why the patient information on the COVID-19 vaccine stated that adverse neurological effects cannot definitively be associated with the vaccine. The patient developed facial numbness within minutes of getting the second shot and she still had it 7 months out. The outcome of the event was not recovered.  The lot number for BNT162B2, was not provided and will be requested during follow up.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Anosmia, Muscle spasms, Sciatica
Clinical narrative: After first shot in Dec 27 2020 I had HORRIBLE right hip pain and went to Priority Care. They stated it was muscle spasm and xray showed nothing.  I was unable to walk for 2 days. Lost taste and smell. All issues resolved that Sunday. Then received my second shot on 1/24/2021. Had intermittent right hip pain but not near as bad as first shot. Did not lose taste and smell. Issues resolved a few days later. Then Feb 8th I noticed my left deltoid hurting like I just got my vaccine. ( I RECEIVED BOTH SHOTS IN LEFT ARM). I did not think too much about it because it went away later that day then I stated to notice  it every so often. Pain deep in my left deltoid where I received my shot. Then it progressed to every day I had pain and it started to intensify. Went to see Dr. who ordered oral Diclofenac Sodium. My issue resolved for about 2 weeks then it came back. Went back to my doctor who sent me to see Orthopedic Dr. He did xrays and examined me. Afterwards he told me I have developed scar tissue at vaccination site. He placed me on a medrol dose pack which did not have much effect on my pain/ burning sensation.  Went back to see PCP Dr. who advised me to not take the booster for CoVid. He ordered a doppler to rule out a bloot clot. I am currently scheduled for 9/9 for this.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Injection site pain, Vaccination site scar, X-ray abnormal
Clinical narrative: After first shot in Dec 27 2020 I had HORRIBLE right hip pain and went to Priority Care. They stated it was muscle spasm and xray showed nothing.  I was unable to walk for 2 days. Lost taste and smell. All issues resolved that Sunday. Then received my second shot on 1/24/2021. Had intermittent right hip pain but not near as bad as first shot. Did not lose taste and smell. Issues resolved a few days later. Then Feb 8th I noticed my left deltoid hurting like I just got my vaccine. ( I RECEIVED BOTH SHOTS IN LEFT ARM). I did not think too much about it because it went away later that day then I stated to notice  it every so often. Pain deep in my left deltoid where I received my shot. Then it progressed to every day I had pain and it started to intensify. Went to see Dr. who ordered oral Diclofenac Sodium. My issue resolved for about 2 weeks then it came back. Went back to my doctor who sent me to see Orthopedic Dr. He did xrays and examined me. Afterwards he told me I have developed scar tissue at vaccination site. He placed me on a medrol dose pack which did not have much effect on my pain/ burning sensation.  Went back to see PCP Dr. who advised me to not take the booster for CoVid. He ordered a doppler to rule out a bloot clot. I am currently scheduled for 9/9 for this.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: Major fatigue for 5 days/tiredness and no energy; headaches 3 to 4 times a day; tiredness and no energy; This is a spontaneous report from a contactable consumer (patient). A 78-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EN9581, Expiration date: Unknown), via an unspecified route of administration, in Left Arm on 07Feb2021 (at the age of 78-years-old) as a DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation at vaccine Health Clinic. The Patient medical history was none. The patient concomitant medications within two weeks included mirtazapine (MIRTAZAPINE) and valsartan (VALSARTAN) both were taken for an unspecified indication, start and stop date were not reported. The patient had no known allergies. The patient did not administered other vaccines in four weeks of vaccination. The patient did not have covid-19, prior vaccination and had not tested for covid-19, post vaccination. On 07Feb2021 at 13:30, the patient had experienced major fatigue for 5 days, headaches 3 to 4 times a day and tiredness and no energy. Patient did not receive any treatment for the events. Outcome of all the events was not recovered.    Follow-up attempts are completed. No further information is expected.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Blood test normal, Diarrhoea, Fatigue, Headache
Clinical narrative: Major fatigue for 5 days/tiredness and no energy; headaches 3 to 4 times a day; tiredness and no energy; This is a spontaneous report from a contactable consumer (patient). A 78-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EN9581, Expiration date: Unknown), via an unspecified route of administration, in Left Arm on 07Feb2021 (at the age of 78-years-old) as a DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation at vaccine Health Clinic. The Patient medical history was none. The patient concomitant medications within two weeks included mirtazapine (MIRTAZAPINE) and valsartan (VALSARTAN) both were taken for an unspecified indication, start and stop date were not reported. The patient had no known allergies. The patient did not administered other vaccines in four weeks of vaccination. The patient did not have covid-19, prior vaccination and had not tested for covid-19, post vaccination. On 07Feb2021 at 13:30, the patient had experienced major fatigue for 5 days, headaches 3 to 4 times a day and tiredness and no energy. Patient did not receive any treatment for the events. Outcome of all the events was not recovered.    Follow-up attempts are completed. No further information is expected.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypersomnia, Renal impairment, Sleep disorder
Clinical narrative: Major fatigue for 5 days/tiredness and no energy; headaches 3 to 4 times a day; tiredness and no energy; This is a spontaneous report from a contactable consumer (patient). A 78-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EN9581, Expiration date: Unknown), via an unspecified route of administration, in Left Arm on 07Feb2021 (at the age of 78-years-old) as a DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation at vaccine Health Clinic. The Patient medical history was none. The patient concomitant medications within two weeks included mirtazapine (MIRTAZAPINE) and valsartan (VALSARTAN) both were taken for an unspecified indication, start and stop date were not reported. The patient had no known allergies. The patient did not administered other vaccines in four weeks of vaccination. The patient did not have covid-19, prior vaccination and had not tested for covid-19, post vaccination. On 07Feb2021 at 13:30, the patient had experienced major fatigue for 5 days, headaches 3 to 4 times a day and tiredness and no energy. Patient did not receive any treatment for the events. Outcome of all the events was not recovered.    Follow-up attempts are completed. No further information is expected.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Fatigue, Headache
Clinical narrative: Major fatigue for 5 days/tiredness and no energy; headaches 3 to 4 times a day; tiredness and no energy; This is a spontaneous report from a contactable consumer (patient). A 78-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EN9581, Expiration date: Unknown), via an unspecified route of administration, in Left Arm on 07Feb2021 (at the age of 78-years-old) as a DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation at vaccine Health Clinic. The Patient medical history was none. The patient concomitant medications within two weeks included mirtazapine (MIRTAZAPINE) and valsartan (VALSARTAN) both were taken for an unspecified indication, start and stop date were not reported. The patient had no known allergies. The patient did not administered other vaccines in four weeks of vaccination. The patient did not have covid-19, prior vaccination and had not tested for covid-19, post vaccination. On 07Feb2021 at 13:30, the patient had experienced major fatigue for 5 days, headaches 3 to 4 times a day and tiredness and no energy. Patient did not receive any treatment for the events. Outcome of all the events was not recovered.    Follow-up attempts are completed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Rash
Clinical narrative: horrible itching; raised rash on lower back; small bumps in various places of body, none on legs or arms; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 69-year-old non-pregnant female patient received unknown dose of bnt162b2 (Pfizer covid-19 vaccine, Solution for injection, Lot number: Unknown), via an unspecified route on 12Feb2021 at 10:45 (age at vaccination: 69-year-old), as a single dose for covid-19 immunization. Medical history included diabetic, both herpes virus and known allergies with Rocephin, Biaxin, Sulfa, Demerol, Morphine, Stadol, Hydrocodone, Mycitracin Ointment, Neosporin Ointment, Mycins, Percodan, Tramadol and Augmentin Toothpaste. Concomitant medications included metformin, iron, omeprazole (PRILOSEC), cyanocobalamin (B12-VITAMIIN) and vitamin D 5000iu. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. On 12Feb2021 at 19:30, patient experienced raised rash on lower back and small bumps in various places of body, none on legs or arms, horrible itching. Patient did not receive any treatment for the events. The clinical outcome of the events was not recovered.  Follow-up attempts completed. No further information expected.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Rash, Skin lesion
Clinical narrative: horrible itching; raised rash on lower back; small bumps in various places of body, none on legs or arms; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 69-year-old non-pregnant female patient received unknown dose of bnt162b2 (Pfizer covid-19 vaccine, Solution for injection, Lot number: Unknown), via an unspecified route on 12Feb2021 at 10:45 (age at vaccination: 69-year-old), as a single dose for covid-19 immunization. Medical history included diabetic, both herpes virus and known allergies with Rocephin, Biaxin, Sulfa, Demerol, Morphine, Stadol, Hydrocodone, Mycitracin Ointment, Neosporin Ointment, Mycins, Percodan, Tramadol and Augmentin Toothpaste. Concomitant medications included metformin, iron, omeprazole (PRILOSEC), cyanocobalamin (B12-VITAMIIN) and vitamin D 5000iu. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. On 12Feb2021 at 19:30, patient experienced raised rash on lower back and small bumps in various places of body, none on legs or arms, horrible itching. Patient did not receive any treatment for the events. The clinical outcome of the events was not recovered.  Follow-up attempts completed. No further information expected.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Rash erythematous
Clinical narrative: red rash on the chest area (under breast); This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 76-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number was not reported, Expiry date: Unknown) via an unspecified route of administration on 08Feb2021 13:00 as dose 1, single in Left arm for COVID-19 immunisation. The patient medical history was not reported. The patient was not pregnant. There were no known allergies. No other vaccine in four weeks. No COVID prior vaccination. Patient was not tested for COVID post vaccination. There were no concomitant medications. On 12Feb2021, the patient experienced red rash on the chest area (under breast). Therapeutic measures were not taken as a result of adverse event. The outcome of the event was unknown.  Follow-up attempts completed. No further information expected.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash erythematous
Clinical narrative: red rash on the chest area (under breast); This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 76-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number was not reported, Expiry date: Unknown) via an unspecified route of administration on 08Feb2021 13:00 as dose 1, single in Left arm for COVID-19 immunisation. The patient medical history was not reported. The patient was not pregnant. There were no known allergies. No other vaccine in four weeks. No COVID prior vaccination. Patient was not tested for COVID post vaccination. There were no concomitant medications. On 12Feb2021, the patient experienced red rash on the chest area (under breast). Therapeutic measures were not taken as a result of adverse event. The outcome of the event was unknown.  Follow-up attempts completed. No further information expected.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mouth ulceration, Oral pain, Swelling face, Ulcer
Clinical narrative: several canker sores and blisters on lip 24 hrs after vaccine; Eyes are puffy - hurt to touch; Small Red dots in mouth Woke up with painful sores/blisters in mouth; Itchy eyes; Small Red dots in mouth Woke up with painful sores/blisters in mouth; several canker sores and blisters on lip 24 hrs after vaccine; This is a spontaneous report from a contactable other healthcare professional. A 27 year old non pregnant female patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Right on 19Feb2021 18:30 (Batch/Lot number was not reported) as DOSE NUMBER, UNKNOWN, SINGLE for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing , allergy to chemicals from an unknown date and unknown if ongoing , allergy to plants and hair dye, sesame seeds from an unknown date and unknown if ongoing. Concomitant medication(s) included vitamin d [vitamin d nos] (VITAMIN D [VITAMIN D NOS]) taken for an unspecified indication, start and stop date were not reported. The patient experienced several canker sores and blisters on lip 24 hrs after vaccine leading to aphthous ulcer on 21Feb2021 with outcome of not recovered , eyes are puffy, hurt to touch leading to periorbital swelling on 21Feb2021 with outcome of not recovered, small red dots in mouth woke up with painful sores or blisters in mouth on 21Feb2021 with outcome of not recovered, itchy eyes on 21Feb2021 with outcome of not recovered. pain 7/10 grading. Therapeutic measures were taken as a result of these events with Ibuprofen and Benadryl   Information of lot and batch number has been requested.  Follow-up (11May2021): Follow-up attempts completed. No further information expected.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Aphthous ulcer, Blister, Eye pruritus, Lip blister, Pain assessment
Clinical narrative: several canker sores and blisters on lip 24 hrs after vaccine; Eyes are puffy - hurt to touch; Small Red dots in mouth Woke up with painful sores/blisters in mouth; Itchy eyes; Small Red dots in mouth Woke up with painful sores/blisters in mouth; several canker sores and blisters on lip 24 hrs after vaccine; This is a spontaneous report from a contactable other healthcare professional. A 27 year old non pregnant female patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Right on 19Feb2021 18:30 (Batch/Lot number was not reported) as DOSE NUMBER, UNKNOWN, SINGLE for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing , allergy to chemicals from an unknown date and unknown if ongoing , allergy to plants and hair dye, sesame seeds from an unknown date and unknown if ongoing. Concomitant medication(s) included vitamin d [vitamin d nos] (VITAMIN D [VITAMIN D NOS]) taken for an unspecified indication, start and stop date were not reported. The patient experienced several canker sores and blisters on lip 24 hrs after vaccine leading to aphthous ulcer on 21Feb2021 with outcome of not recovered , eyes are puffy, hurt to touch leading to periorbital swelling on 21Feb2021 with outcome of not recovered, small red dots in mouth woke up with painful sores or blisters in mouth on 21Feb2021 with outcome of not recovered, itchy eyes on 21Feb2021 with outcome of not recovered. pain 7/10 grading. Therapeutic measures were taken as a result of these events with Ibuprofen and Benadryl   Information of lot and batch number has been requested.  Follow-up (11May2021): Follow-up attempts completed. No further information expected.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Periorbital swelling, Stomatitis
Clinical narrative: several canker sores and blisters on lip 24 hrs after vaccine; Eyes are puffy - hurt to touch; Small Red dots in mouth Woke up with painful sores/blisters in mouth; Itchy eyes; Small Red dots in mouth Woke up with painful sores/blisters in mouth; several canker sores and blisters on lip 24 hrs after vaccine; This is a spontaneous report from a contactable other healthcare professional. A 27 year old non pregnant female patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Right on 19Feb2021 18:30 (Batch/Lot number was not reported) as DOSE NUMBER, UNKNOWN, SINGLE for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing , allergy to chemicals from an unknown date and unknown if ongoing , allergy to plants and hair dye, sesame seeds from an unknown date and unknown if ongoing. Concomitant medication(s) included vitamin d [vitamin d nos] (VITAMIN D [VITAMIN D NOS]) taken for an unspecified indication, start and stop date were not reported. The patient experienced several canker sores and blisters on lip 24 hrs after vaccine leading to aphthous ulcer on 21Feb2021 with outcome of not recovered , eyes are puffy, hurt to touch leading to periorbital swelling on 21Feb2021 with outcome of not recovered, small red dots in mouth woke up with painful sores or blisters in mouth on 21Feb2021 with outcome of not recovered, itchy eyes on 21Feb2021 with outcome of not recovered. pain 7/10 grading. Therapeutic measures were taken as a result of these events with Ibuprofen and Benadryl   Information of lot and batch number has been requested.  Follow-up (11May2021): Follow-up attempts completed. No further information expected.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Dysgeusia, Erythema, Fatigue, Headache
Clinical narrative: Bitter taste in mouth when injected & lasted for few days.; Headache; Nausea; Muscle and joint pain; Injection site pain, redness and swelling; Injection site pain, redness and swelling; Injection site pain, redness and swelling; Slight fever; Feeling unwell; Muscle and joint pain; This is a spontaneous report from a contactable consumer (Patient). A 67-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3249), via an unspecified route of administration, on 10Feb2021 at 02:00 PM (at the age of 67-year-old), as dose 1, single for COVID-19 immunization at Physician Office. Patient's medical history included thyroid and all para-thyroids removed, kidney disease and stones, migraine. Patient had known allergies to sulfa drugs, perfume, and dyes. The patient's past drugs included Z-PAK, Voltaren gel; and experienced allergies. Concomitant medications in 2 weeks of vaccination included levothyroxine, calcitriol, magnesium oxide (MAGOX), calcium citrate and vitamin D; all taken for unspecified indications, start and stop dates were not reported. Patient did not receive other vaccine in four weeks of COVID vaccination. On 10Feb2021 at 16:00, 2 hours after first dose of vaccine, the patient experienced bitter taste in mouth when injected and lasted for few days, two hours later she had headache; nausea; muscle and joint pain; injection site pain, redness and swelling; slight fever and was feeling unwell. The patient underwent lab test and procedure includes SARS-CoV-2 test: negative, on 22Dec2021. Patient did not receive treatment for adverse events. The patient had no COVID prior vaccination and was tested COVID post vaccination. The clinical outcome of all events was resolved on unspecified dates in 2021.   Follow-up attempts completed. No further information expected
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immediate post-injection reaction, Injection site pain, Malaise, Myalgia, Pyrexia
Clinical narrative: Bitter taste in mouth when injected & lasted for few days.; Headache; Nausea; Muscle and joint pain; Injection site pain, redness and swelling; Injection site pain, redness and swelling; Injection site pain, redness and swelling; Slight fever; Feeling unwell; Muscle and joint pain; This is a spontaneous report from a contactable consumer (Patient). A 67-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3249), via an unspecified route of administration, on 10Feb2021 at 02:00 PM (at the age of 67-year-old), as dose 1, single for COVID-19 immunization at Physician Office. Patient's medical history included thyroid and all para-thyroids removed, kidney disease and stones, migraine. Patient had known allergies to sulfa drugs, perfume, and dyes. The patient's past drugs included Z-PAK, Voltaren gel; and experienced allergies. Concomitant medications in 2 weeks of vaccination included levothyroxine, calcitriol, magnesium oxide (MAGOX), calcium citrate and vitamin D; all taken for unspecified indications, start and stop dates were not reported. Patient did not receive other vaccine in four weeks of COVID vaccination. On 10Feb2021 at 16:00, 2 hours after first dose of vaccine, the patient experienced bitter taste in mouth when injected and lasted for few days, two hours later she had headache; nausea; muscle and joint pain; injection site pain, redness and swelling; slight fever and was feeling unwell. The patient underwent lab test and procedure includes SARS-CoV-2 test: negative, on 22Dec2021. Patient did not receive treatment for adverse events. The patient had no COVID prior vaccination and was tested COVID post vaccination. The clinical outcome of all events was resolved on unspecified dates in 2021.   Follow-up attempts completed. No further information expected
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling
Clinical narrative: Bitter taste in mouth when injected & lasted for few days.; Headache; Nausea; Muscle and joint pain; Injection site pain, redness and swelling; Injection site pain, redness and swelling; Injection site pain, redness and swelling; Slight fever; Feeling unwell; Muscle and joint pain; This is a spontaneous report from a contactable consumer (Patient). A 67-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3249), via an unspecified route of administration, on 10Feb2021 at 02:00 PM (at the age of 67-year-old), as dose 1, single for COVID-19 immunization at Physician Office. Patient's medical history included thyroid and all para-thyroids removed, kidney disease and stones, migraine. Patient had known allergies to sulfa drugs, perfume, and dyes. The patient's past drugs included Z-PAK, Voltaren gel; and experienced allergies. Concomitant medications in 2 weeks of vaccination included levothyroxine, calcitriol, magnesium oxide (MAGOX), calcium citrate and vitamin D; all taken for unspecified indications, start and stop dates were not reported. Patient did not receive other vaccine in four weeks of COVID vaccination. On 10Feb2021 at 16:00, 2 hours after first dose of vaccine, the patient experienced bitter taste in mouth when injected and lasted for few days, two hours later she had headache; nausea; muscle and joint pain; injection site pain, redness and swelling; slight fever and was feeling unwell. The patient underwent lab test and procedure includes SARS-CoV-2 test: negative, on 22Dec2021. Patient did not receive treatment for adverse events. The patient had no COVID prior vaccination and was tested COVID post vaccination. The clinical outcome of all events was resolved on unspecified dates in 2021.   Follow-up attempts completed. No further information expected
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Dysgeusia, Headache, Malaise, Myalgia
Clinical narrative: Bitter taste in mouth when injected & lasted for few days.; Headache; Nausea; Muscle and joint pain; Injection site pain, redness and swelling; Injection site pain, redness and swelling; Injection site pain, redness and swelling; Slight fever; Feeling unwell; Muscle and joint pain; This is a spontaneous report from a contactable consumer (Patient). A 67-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3249), via an unspecified route of administration, on 10Feb2021 at 02:00 PM (at the age of 67-year-old), as dose 1, single for COVID-19 immunization at Physician Office. Patient's medical history included thyroid and all para-thyroids removed, kidney disease and stones, migraine. Patient had known allergies to sulfa drugs, perfume, and dyes. The patient's past drugs included Z-PAK, Voltaren gel; and experienced allergies. Concomitant medications in 2 weeks of vaccination included levothyroxine, calcitriol, magnesium oxide (MAGOX), calcium citrate and vitamin D; all taken for unspecified indications, start and stop dates were not reported. Patient did not receive other vaccine in four weeks of COVID vaccination. On 10Feb2021 at 16:00, 2 hours after first dose of vaccine, the patient experienced bitter taste in mouth when injected and lasted for few days, two hours later she had headache; nausea; muscle and joint pain; injection site pain, redness and swelling; slight fever and was feeling unwell. The patient underwent lab test and procedure includes SARS-CoV-2 test: negative, on 22Dec2021. Patient did not receive treatment for adverse events. The patient had no COVID prior vaccination and was tested COVID post vaccination. The clinical outcome of all events was resolved on unspecified dates in 2021.   Follow-up attempts completed. No further information expected
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pyrexia, SARS-CoV-2 test, Vaccination site erythema, Vaccination site pain
Clinical narrative: Bitter taste in mouth when injected & lasted for few days.; Headache; Nausea; Muscle and joint pain; Injection site pain, redness and swelling; Injection site pain, redness and swelling; Injection site pain, redness and swelling; Slight fever; Feeling unwell; Muscle and joint pain; This is a spontaneous report from a contactable consumer (Patient). A 67-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3249), via an unspecified route of administration, on 10Feb2021 at 02:00 PM (at the age of 67-year-old), as dose 1, single for COVID-19 immunization at Physician Office. Patient's medical history included thyroid and all para-thyroids removed, kidney disease and stones, migraine. Patient had known allergies to sulfa drugs, perfume, and dyes. The patient's past drugs included Z-PAK, Voltaren gel; and experienced allergies. Concomitant medications in 2 weeks of vaccination included levothyroxine, calcitriol, magnesium oxide (MAGOX), calcium citrate and vitamin D; all taken for unspecified indications, start and stop dates were not reported. Patient did not receive other vaccine in four weeks of COVID vaccination. On 10Feb2021 at 16:00, 2 hours after first dose of vaccine, the patient experienced bitter taste in mouth when injected and lasted for few days, two hours later she had headache; nausea; muscle and joint pain; injection site pain, redness and swelling; slight fever and was feeling unwell. The patient underwent lab test and procedure includes SARS-CoV-2 test: negative, on 22Dec2021. Patient did not receive treatment for adverse events. The patient had no COVID prior vaccination and was tested COVID post vaccination. The clinical outcome of all events was resolved on unspecified dates in 2021.   Follow-up attempts completed. No further information expected
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Bitter taste in mouth when injected & lasted for few days.; Headache; Nausea; Muscle and joint pain; Injection site pain, redness and swelling; Injection site pain, redness and swelling; Injection site pain, redness and swelling; Slight fever; Feeling unwell; Muscle and joint pain; This is a spontaneous report from a contactable consumer (Patient). A 67-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3249), via an unspecified route of administration, on 10Feb2021 at 02:00 PM (at the age of 67-year-old), as dose 1, single for COVID-19 immunization at Physician Office. Patient's medical history included thyroid and all para-thyroids removed, kidney disease and stones, migraine. Patient had known allergies to sulfa drugs, perfume, and dyes. The patient's past drugs included Z-PAK, Voltaren gel; and experienced allergies. Concomitant medications in 2 weeks of vaccination included levothyroxine, calcitriol, magnesium oxide (MAGOX), calcium citrate and vitamin D; all taken for unspecified indications, start and stop dates were not reported. Patient did not receive other vaccine in four weeks of COVID vaccination. On 10Feb2021 at 16:00, 2 hours after first dose of vaccine, the patient experienced bitter taste in mouth when injected and lasted for few days, two hours later she had headache; nausea; muscle and joint pain; injection site pain, redness and swelling; slight fever and was feeling unwell. The patient underwent lab test and procedure includes SARS-CoV-2 test: negative, on 22Dec2021. Patient did not receive treatment for adverse events. The patient had no COVID prior vaccination and was tested COVID post vaccination. The clinical outcome of all events was resolved on unspecified dates in 2021.   Follow-up attempts completed. No further information expected
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Ageusia, Asthenia, Chest discomfort, Chills
Clinical narrative: upset stomach; dehydration; eyes were red; fatigue; chest tightness; Loss of taste; This is a spontaneous report from a contactable other healthcare professional. A 37 year old female patient received bnt162b2 (BNT162B2), dose 2 intramuscular, administered in Arm Right on 19Jan2021 (Batch/Lot Number: EL1283) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced fatigue, chest tightness, upset stomach, dehydration, eyes were red leading to ocular hyperaemia and loss of taste leading to ageusia on 19Jan2021 23:00 with outcome of unknown. Symptoms reoccurred with 2nd dose of covid-19 vaccine, only worse. Had more side effects with the 2nd dose. In which she also filled out a separate questionnaire for. Did not have adverse side effects as far as she know that were serious enough to require immediate medical attention. Took 8 hours after shot before any side effects. Therapeutic antipyretic use:Midol(1st vaccine) plus Tylenol (2nd vaccine)  Follow-up (14May2021): Follow-up attempts completed. No further information expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Decreased appetite, Dehydration, Fatigue, Myalgia, Panic attack
Clinical narrative: upset stomach; dehydration; eyes were red; fatigue; chest tightness; Loss of taste; This is a spontaneous report from a contactable other healthcare professional. A 37 year old female patient received bnt162b2 (BNT162B2), dose 2 intramuscular, administered in Arm Right on 19Jan2021 (Batch/Lot Number: EL1283) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced fatigue, chest tightness, upset stomach, dehydration, eyes were red leading to ocular hyperaemia and loss of taste leading to ageusia on 19Jan2021 23:00 with outcome of unknown. Symptoms reoccurred with 2nd dose of covid-19 vaccine, only worse. Had more side effects with the 2nd dose. In which she also filled out a separate questionnaire for. Did not have adverse side effects as far as she know that were serious enough to require immediate medical attention. Took 8 hours after shot before any side effects. Therapeutic antipyretic use:Midol(1st vaccine) plus Tylenol (2nd vaccine)  Follow-up (14May2021): Follow-up attempts completed. No further information expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: upset stomach; dehydration; eyes were red; fatigue; chest tightness; Loss of taste; This is a spontaneous report from a contactable other healthcare professional. A 37 year old female patient received bnt162b2 (BNT162B2), dose 2 intramuscular, administered in Arm Right on 19Jan2021 (Batch/Lot Number: EL1283) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced fatigue, chest tightness, upset stomach, dehydration, eyes were red leading to ocular hyperaemia and loss of taste leading to ageusia on 19Jan2021 23:00 with outcome of unknown. Symptoms reoccurred with 2nd dose of covid-19 vaccine, only worse. Had more side effects with the 2nd dose. In which she also filled out a separate questionnaire for. Did not have adverse side effects as far as she know that were serious enough to require immediate medical attention. Took 8 hours after shot before any side effects. Therapeutic antipyretic use:Midol(1st vaccine) plus Tylenol (2nd vaccine)  Follow-up (14May2021): Follow-up attempts completed. No further information expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Ageusia, Chest discomfort, Dehydration, Fatigue
Clinical narrative: upset stomach; dehydration; eyes were red; fatigue; chest tightness; Loss of taste; This is a spontaneous report from a contactable other healthcare professional. A 37 year old female patient received bnt162b2 (BNT162B2), dose 2 intramuscular, administered in Arm Right on 19Jan2021 (Batch/Lot Number: EL1283) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced fatigue, chest tightness, upset stomach, dehydration, eyes were red leading to ocular hyperaemia and loss of taste leading to ageusia on 19Jan2021 23:00 with outcome of unknown. Symptoms reoccurred with 2nd dose of covid-19 vaccine, only worse. Had more side effects with the 2nd dose. In which she also filled out a separate questionnaire for. Did not have adverse side effects as far as she know that were serious enough to require immediate medical attention. Took 8 hours after shot before any side effects. Therapeutic antipyretic use:Midol(1st vaccine) plus Tylenol (2nd vaccine)  Follow-up (14May2021): Follow-up attempts completed. No further information expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ocular hyperaemia
Clinical narrative: upset stomach; dehydration; eyes were red; fatigue; chest tightness; Loss of taste; This is a spontaneous report from a contactable other healthcare professional. A 37 year old female patient received bnt162b2 (BNT162B2), dose 2 intramuscular, administered in Arm Right on 19Jan2021 (Batch/Lot Number: EL1283) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced fatigue, chest tightness, upset stomach, dehydration, eyes were red leading to ocular hyperaemia and loss of taste leading to ageusia on 19Jan2021 23:00 with outcome of unknown. Symptoms reoccurred with 2nd dose of covid-19 vaccine, only worse. Had more side effects with the 2nd dose. In which she also filled out a separate questionnaire for. Did not have adverse side effects as far as she know that were serious enough to require immediate medical attention. Took 8 hours after shot before any side effects. Therapeutic antipyretic use:Midol(1st vaccine) plus Tylenol (2nd vaccine)  Follow-up (14May2021): Follow-up attempts completed. No further information expected.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Two days later tinnitus began n left ear; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EN6203) via an unspecified route of administration in the arm right on 04Mar2021 at 12:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications within two weeks of receiving the vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Mar2021 the patient experienced tinnitus began n left ear. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of tinnitus and included treatment with steroids starting from an unknown date. The clinical outcome of the event tinnitus  was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Basophil count increased, Chest pain, Chills, Lymphadenopathy, Magnetic resonance imaging abnormal
Clinical narrative: Lymph nodes under arm hurt; Fever; Chills; Muscle aches and pain; Truly feeling lousy; Headache; Itchy but no hives; nausea; Weak; This is a spontaneous report from a contactable consumer (patient herself). A 68-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9267), via an unspecified route of administration, administered in right arm on 23Feb2021 10:00 (age at vaccination: 68 years) as DOSE 2, Single for covid-19 immunisation. The patient's medical history included ongoing just diagnosed with ductal carcinoma in situ breast cancer (recently had mri with contrast). The patient's concomitant medications were not reported. The patient did not have no known allergies. The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unknown date as DOSE 1, single. The patient did not have any other vaccine in four weeks. On 23Feb2021 22:15, the patient experienced lymph nodes under arm hurt, fever, chills, muscle aches and pain, truly feeling lousy, headache, itchy but no hives, nausea and weak. The patient received Tylenol as treatment for the adverse events. On 23Feb2021, the patient's body temperature was 100 and on an unknown date, magnetic resonance imaging with unknown result. The patient did not have covid prior vaccination nor was tested since vaccination. The outcome of the events was not recovered.   Follow-up attempts completed. No further information expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mean cell volume decreased, Pain, Pyrexia, Sleep disorder, Vertigo
Clinical narrative: Lymph nodes under arm hurt; Fever; Chills; Muscle aches and pain; Truly feeling lousy; Headache; Itchy but no hives; nausea; Weak; This is a spontaneous report from a contactable consumer (patient herself). A 68-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9267), via an unspecified route of administration, administered in right arm on 23Feb2021 10:00 (age at vaccination: 68 years) as DOSE 2, Single for covid-19 immunisation. The patient's medical history included ongoing just diagnosed with ductal carcinoma in situ breast cancer (recently had mri with contrast). The patient's concomitant medications were not reported. The patient did not have no known allergies. The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unknown date as DOSE 1, single. The patient did not have any other vaccine in four weeks. On 23Feb2021 22:15, the patient experienced lymph nodes under arm hurt, fever, chills, muscle aches and pain, truly feeling lousy, headache, itchy but no hives, nausea and weak. The patient received Tylenol as treatment for the adverse events. On 23Feb2021, the patient's body temperature was 100 and on an unknown date, magnetic resonance imaging with unknown result. The patient did not have covid prior vaccination nor was tested since vaccination. The outcome of the events was not recovered.   Follow-up attempts completed. No further information expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Body temperature, Chills, Headache, Lymph node pain
Clinical narrative: Lymph nodes under arm hurt; Fever; Chills; Muscle aches and pain; Truly feeling lousy; Headache; Itchy but no hives; nausea; Weak; This is a spontaneous report from a contactable consumer (patient herself). A 68-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9267), via an unspecified route of administration, administered in right arm on 23Feb2021 10:00 (age at vaccination: 68 years) as DOSE 2, Single for covid-19 immunisation. The patient's medical history included ongoing just diagnosed with ductal carcinoma in situ breast cancer (recently had mri with contrast). The patient's concomitant medications were not reported. The patient did not have no known allergies. The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unknown date as DOSE 1, single. The patient did not have any other vaccine in four weeks. On 23Feb2021 22:15, the patient experienced lymph nodes under arm hurt, fever, chills, muscle aches and pain, truly feeling lousy, headache, itchy but no hives, nausea and weak. The patient received Tylenol as treatment for the adverse events. On 23Feb2021, the patient's body temperature was 100 and on an unknown date, magnetic resonance imaging with unknown result. The patient did not have covid prior vaccination nor was tested since vaccination. The outcome of the events was not recovered.   Follow-up attempts completed. No further information expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging, Malaise, Myalgia, Nausea, Pruritus
Clinical narrative: Lymph nodes under arm hurt; Fever; Chills; Muscle aches and pain; Truly feeling lousy; Headache; Itchy but no hives; nausea; Weak; This is a spontaneous report from a contactable consumer (patient herself). A 68-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9267), via an unspecified route of administration, administered in right arm on 23Feb2021 10:00 (age at vaccination: 68 years) as DOSE 2, Single for covid-19 immunisation. The patient's medical history included ongoing just diagnosed with ductal carcinoma in situ breast cancer (recently had mri with contrast). The patient's concomitant medications were not reported. The patient did not have no known allergies. The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unknown date as DOSE 1, single. The patient did not have any other vaccine in four weeks. On 23Feb2021 22:15, the patient experienced lymph nodes under arm hurt, fever, chills, muscle aches and pain, truly feeling lousy, headache, itchy but no hives, nausea and weak. The patient received Tylenol as treatment for the adverse events. On 23Feb2021, the patient's body temperature was 100 and on an unknown date, magnetic resonance imaging with unknown result. The patient did not have covid prior vaccination nor was tested since vaccination. The outcome of the events was not recovered.   Follow-up attempts completed. No further information expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Lymph nodes under arm hurt; Fever; Chills; Muscle aches and pain; Truly feeling lousy; Headache; Itchy but no hives; nausea; Weak; This is a spontaneous report from a contactable consumer (patient herself). A 68-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9267), via an unspecified route of administration, administered in right arm on 23Feb2021 10:00 (age at vaccination: 68 years) as DOSE 2, Single for covid-19 immunisation. The patient's medical history included ongoing just diagnosed with ductal carcinoma in situ breast cancer (recently had mri with contrast). The patient's concomitant medications were not reported. The patient did not have no known allergies. The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unknown date as DOSE 1, single. The patient did not have any other vaccine in four weeks. On 23Feb2021 22:15, the patient experienced lymph nodes under arm hurt, fever, chills, muscle aches and pain, truly feeling lousy, headache, itchy but no hives, nausea and weak. The patient received Tylenol as treatment for the adverse events. On 23Feb2021, the patient's body temperature was 100 and on an unknown date, magnetic resonance imaging with unknown result. The patient did not have covid prior vaccination nor was tested since vaccination. The outcome of the events was not recovered.   Follow-up attempts completed. No further information expected.